Pulsatile Cupping in Low Back Pain
Not Applicable
Completed
- Conditions
- Chronic Low Back Pain
- Interventions
- Device: Minimal CuppingDevice: Pulsatile Cupping
- Registration Number
- NCT02090686
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The purpose of this study is to determine whether pulsatile cupping with a cupping device is effective in the treatment of patients with chronic low back pain compared to no cupping or to minimal cupping.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
- Male and female, 18-65 years
- Chronic low back pain (disease duration > 3 months)
- Pain intensity on visual analogue scale at inclusion > 40 mm (0-100 mm scale)
- Only pharmacological treatment with NSAID or no treatment in the last 4 weeks
- Undersigned informed consent form
Exclusion Criteria
- Use of anticoagulants (Phenprocoumon, Heparin)
- Coagulopathy
- Cupping in the last 6 weeks
- Other CAM therapies in the last 12 weeks (e.g. acupuncture)
- Physical therapy in the last 12 weeks (e.g. massage, osteopathy)
- participation in another study in the last 3 months
- Paracetamol allergy or intolerance
- Pathological neurological symptoms such as muscular paralysis or paraesthesia due to spinal disc herniation or other causes
- Known renal and / or hepatic diseases
- Intake of central nervous system-acting analgesics in the last 6 weeks
- Applying for early retirement due to low back pain
- Severe disease that does not allow participation
- No undersigned informed consent form
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Minimal Cupping Minimal Cupping - Pulsatile Cupping Pulsatile Cupping -
- Primary Outcome Measures
Name Time Method Intensity of pain on visual analogues scale 4 weeks
- Secondary Outcome Measures
Name Time Method Intensity of pain on visual analogue scale 12 weeks Back function - FFbH-R-Questionnaire 4 weeks, 12 weeks Quality of Life - SF 36 4 weeks, 12 weeks Assessment of perceived effect on Likert Scale 4 weeks, 12 weeks Intake of paracetamol 4 weeks Adverse events week 1- 12
Trial Locations
- Locations (1)
Charité Universitätsmedizin Berlin
🇩🇪Berlin, Germany